Tumor samples were analyzed for : epidermal growth factor receptor ( EGFR ) expression ( immunohistochemistry [ IHC ] ) ; EGFR gene copy number ( fluorescence in-situ hybridization [ FISH ] ) ; EGFR mutations ( exon 19 deletions/L858R mutations ) ; and KRAS mutations ( exons 2/3 ) .